Rhys J Morris1, John P Woodcock. 1. Department of Medical Physics and Clinical Engineering, University Hospital of Wales, Cardiff, Wales, United Kingdom. morrisrj@cf.ac.uk
Abstract
OBJECTIVE: To review the relative efficacy of intermittent pneumatic compression (IPC) and graduated compression stockings (GCS) stated in direct clinical comparisons. SUMMARY BACKGROUND DATA: Both IPC and GCS are recommended for deep vein thrombosis (DVT) prophylaxis in surgical patients. Although both are known to be effective, guidance is less clear on the clinical grounds for choosing between the 2 devices. METHODS: Major medical databases were searched for trial reports published between January 1970 and August 2008. All trials comprising a direct clinical comparison between IPC and GCS were reviewed. RESULTS: Ten direct comparisons were found, 9 of which were with surgical patients. The difference in DVT outcome only reached statistic significance in 3, all of which showed IPC to have the lower DVT rate. Five of the trials that did not produce statistic significance included fewer than 40 patients in each study group. The crude cumulated DVT rate for all the trials was 5.9% for GCS and 2.8% for IPC. CONCLUSION: There is only weak evidence to show a difference in performance between the devices, however, given the many influential factors, caution should be taken in assuming equivalence.
OBJECTIVE: To review the relative efficacy of intermittent pneumatic compression (IPC) and graduated compression stockings (GCS) stated in direct clinical comparisons. SUMMARY BACKGROUND DATA: Both IPC and GCS are recommended for deep vein thrombosis (DVT) prophylaxis in surgical patients. Although both are known to be effective, guidance is less clear on the clinical grounds for choosing between the 2 devices. METHODS: Major medical databases were searched for trial reports published between January 1970 and August 2008. All trials comprising a direct clinical comparison between IPC and GCS were reviewed. RESULTS: Ten direct comparisons were found, 9 of which were with surgical patients. The difference in DVT outcome only reached statistic significance in 3, all of which showed IPC to have the lower DVT rate. Five of the trials that did not produce statistic significance included fewer than 40 patients in each study group. The crude cumulated DVT rate for all the trials was 5.9% for GCS and 2.8% for IPC. CONCLUSION: There is only weak evidence to show a difference in performance between the devices, however, given the many influential factors, caution should be taken in assuming equivalence.
Authors: Donald E Low; William Allum; Giovanni De Manzoni; Lorenzo Ferri; Arul Immanuel; MadhanKumar Kuppusamy; Simon Law; Mats Lindblad; Nick Maynard; Joseph Neal; C S Pramesh; Mike Scott; B Mark Smithers; Valérie Addor; Olle Ljungqvist Journal: World J Surg Date: 2019-02 Impact factor: 3.352
Authors: Thomas A Aloia; William H Geerts; Bryan M Clary; Ryan W Day; Alan W Hemming; Luiz Carneiro D'Albuquerque; Charles M Vollmer; Jean-Nicolas Vauthey; Giles J Toogood Journal: J Gastrointest Surg Date: 2016-01 Impact factor: 3.452
Authors: David R Anderson; Gian Paolo Morgano; Carole Bennett; Francesco Dentali; Charles W Francis; David A Garcia; Susan R Kahn; Maryam Rahman; Anita Rajasekhar; Frederick B Rogers; Maureen A Smythe; Kari A O Tikkinen; Adolph J Yates; Tejan Baldeh; Sara Balduzzi; Jan L Brożek; Itziar Etxeandia- Ikobaltzeta; Herman Johal; Ignacio Neumann; Wojtek Wiercioch; Juan José Yepes-Nuñez; Holger J Schünemann; Philipp Dahm Journal: Blood Adv Date: 2019-12-10
Authors: Francesco Paciullo; Loredana Bury; Patrizia Noris; Emanuela Falcinelli; Federica Melazzini; Sara Orsini; Carlo Zaninetti; Rezan Abdul-Kadir; Deborah Obeng-Tuudah; Paula G Heller; Ana C Glembotsky; Fabrizio Fabris; Jose Rivera; Maria Luisa Lozano; Nora Butta; Remi Favier; Ana Rosa Cid; Marc Fouassier; Gian Marco Podda; Cristina Santoro; Elvira Grandone; Yvonne Henskens; Paquita Nurden; Barbara Zieger; Adam Cuker; Katrien Devreese; Alberto Tosetto; Erica De Candia; Arnaud Dupuis; Koji Miyazaki; Maha Othman; Paolo Gresele Journal: Haematologica Date: 2019-09-26 Impact factor: 9.941